Occudo Quantitative Strategies’s Sensus Healthcare SRTS Stock Holding History

Occudo Quantitative Strategies’s Portfolio SRTS Stock Details SRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,692	Closed	-$74K	–	902
2024 Q4	$74K	Sell	10,692 -5,057	-32%	-$37.1K	0.01%	642
2024 Q3	$91.3K	Sell	15,749 -7,110	-31%	-$43.2K	0.02%	644
2024 Q2	$122K	Buy	+22,859	New	+$105K	0.02%	650
2022 Q4	–	Sell	-15,723	Closed	-$197K	–	1342
2022 Q3	$197K	Sell	15,723 -2,467	-14%	-$29.5K	0.02%	968
2022 Q2	$140K	Buy	18,190 +4,830	+36%	+$40.5K	0.01%	970
2022 Q1	$135K	Buy	+13,360	New	+$122K	0.01%	998

Other funds holding SRTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Occudo Quantitative Strategies's SRTS Position: Q1 2025 in Review

Occudo Quantitative Strategies sold out of Sensus Healthcare (SRTS) in Q1 2025, closing a stake of 10,692 shares — an estimated $74K sold.

Occudo Quantitative Strategies first reported a position in SRTS in Q1 2022 and held it in 6 quarters. The position peaked at $197K in Q3 2022. 53 funds tracked by Wall St. Rank hold SRTS as of Q1 2025.

Occudo Quantitative Strategies reported no remaining Sensus Healthcare position as of Q1 2025 after selling out during the quarter.
Occudo Quantitative Strategies sold 10,692 Sensus Healthcare shares in Q1 2025, an estimated $74K.
Occudo Quantitative Strategies first reported a position in Sensus Healthcare in Q1 2022 and held it in 6 quarters.
Occudo Quantitative Strategies's Sensus Healthcare position peaked at $197K in Q3 2022.
53 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2025, filed 15 May 2025.